Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-064589
Filing Date
2025-05-06
Accepted
2025-05-06 17:00:45
Documents
19
Effectiveness Date
2025-05-06

Document Format Files

Seq Description Document Type Size
1 S-8 hrtx-20250506.htm S-8 159978
2 EX-5.1 hrtx-ex5_1.htm EX-5.1 21430
3 EX-23.2 hrtx-ex23_2.htm EX-23.2 4249
4 EX-99.1 hrtx-ex99_1.htm EX-99.1 37394
5 EX-99.2 hrtx-ex99_2.htm EX-99.2 37230
6 EX-99.3 hrtx-ex99_3.htm EX-99.3 13683
7 EX-FILING FEES hrtx_exfilingfees.htm   iXBRL EX-FILING FEES 51773
8 GRAPHIC img170582792_0.jpg GRAPHIC 11158
  Complete submission text file 0000950170-25-064589.txt   500554

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT hrtx_exfilingfees_htm.xml XML 19790
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-287008 | Film No.: 25918145
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)